PHI BioMed
PrivateLast Round
Strategic
May 11, 2022
Est. Valuation
$9.7M
Total Funding Raised
$850,000
Company Overview
PHI BioMed operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Strategic round in May 2022.
PHI BioMed is a biopharmaceutical company that develops cosmetic surgery products, medical materials, biomedical drug delivery systems, and regenerative medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Advanced Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PHI BioMed Comparables
Compare PHI BioMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nexgel Biotech Co., Ltd. | 80% | |
| Pnaseer Inc. | 76% | |
| LG Chem | 74% |
For institutional investors. Book with your work email.
PHI BioMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 11, 2022 | ||||
| Strategic | Jun 8, 2018 | ||||
| Seed | Oct 1, 2017 |
For institutional investors. Book with your work email.
PHI BioMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| POSTECH Holdings Co., Ltd. | Seed |
| POSCO Technology Investment | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2017
Seed round raised with POSCO Technology Investment and POSTECH Holdings.
For institutional investors. Book with your work email.
PHI BioMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PHI BioMed's valuation, stock price, and market status.
Is PHI BioMed a public or private company?
PHI BioMed is a private company.
What is the current stock price of PHI BioMed?
PHI BioMed is a private company, so its shares have no public market price. Caplight tracks PHI BioMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PHI BioMed worth (valuation)?
PHI BioMed's valuation is estimated at $9.7M based on funding round data.
Can I buy PHI BioMed stock?
PHI BioMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PHI BioMed's last funding round?
PHI BioMed's most recent funding round was Strategic on May 11, 2022.
Who are the main investors in PHI BioMed?
Key investors in PHI BioMed include POSTECH Holdings Co., Ltd., POSCO Technology Investment.
Will PHI BioMed IPO soon?
No public IPO plans have been announced for PHI BioMed.
How can I track PHI BioMed secondary market activity?
Caplight tracks bids, offers, and trades in PHI BioMed's shares on secondary markets.